A client with opioid use disorder on buprenorphine also has hepatic impairment. Which concern is MOST clinically relevant?
-
A
Buprenorphine is renally cleared so liver disease is irrelevant
-
B
Buprenorphine is hepatically metabolized via CYP3A4; severe impairment may increase plasma levels
-
C
Hepatic impairment accelerates buprenorphine metabolism, requiring higher doses
-
D
Naloxone in the combination formulation is toxic to damaged liver cells